Christine Blank
Contributing Editor Christine Blank is a freelance writer based in Florida.
Samsung Gets First U.S. Approval
The second Remicade biosimilar is only the fifth biosimilar approved in the United States.
Pharmacists Are Flying In to Washington to Talk and Persuade
DIR fees top pharmacy legislator meetings.
Is $485 million enough to end the opioid epidemic?
Is $485 million enough to end the opioid epidemic?
The HHS is giving out greatly needed funds, but money alone may not be enough.
Pharmacists and Patients Worry About Naloxone Dispensing
Pharmacists and Patients Worry About Naloxone Dispensing
Naloxone is available, but is it actually being used?
Inside the $100 Million Opioids Ring
Inside the $100 Million Opioids Ring
How physicians made millions and fed the opioid epidemic.
Fred's Could Help Rite Aid/Walgreens Deal Go Through
The chain has said it remains committed to buying Rite Aid stores.
The Trump Administration Gets Tough on Opioids
The Trump Administration Gets Tough on Opioids
Trump and Gottlieb are both taking steps to end the opioid epidemic. But is it enough?
MS Group Praises New Drug Despite High Price Tag
MS Group Praises New Drug Despite High Price Tag
Why a drug that costs $65,000 a year is making patient groups happy.
New York City Program Aims to Slash Opioid Deaths
New York City Program Aims to Slash Opioid Deaths
What New York City is doing to curb the opioid epidemic.
Pharmacists to Descend on Washington
Pharmacists to Descend on Washington
DIR fees and health-care reform will lead pharmacists’ legislative concerns.

Poll

View Results